Evidence map›Paper›PMID 39446721›Full record

Trial reportPLoS medicine2024

The effect of protecting women against economic shocks to fight HIV in Cameroon, Africa: The POWER randomised controlled trial.

Aurélia Lépine, Sandie Szawlowski, Emile Nitcheu, Henry Cust, Eric Defo Tamgno, Julienne Noo, Fanny Procureur, Illiasou Mfochive, Serge Billong, Ubald Tamoufe

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in PLoS medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aurélia LépineUniversity College London, Institute for Global Health, London, United Kingdom.ORCID 0000-0002-9237-2914
Sandie SzawlowskiUniversity College London, Institute for Global Health, London, United Kingdom.ORCID 0000-0002-8793-8039
Emile NitcheuJohn Hopkins Cameroon Program, Yaounde, Cameroon.
Henry CustUniversity College London, Institute for Global Health, London, United Kingdom.ORCID 0000-0002-4868-5729
Eric Defo TamgnoJohn Hopkins Cameroon Program, Yaounde, Cameroon.
Julienne NooJohn Hopkins Cameroon Program, Yaounde, Cameroon.
Fanny ProcureurUniversity College London, Institute for Global Health, London, United Kingdom.
Illiasou MfochiveJohn Hopkins Cameroon Program, Yaounde, Cameroon.
Serge BillongUniversity of Yaounde I, Yaounde, Cameroon.
Ubald TamoufeJohn Hopkins Cameroon Program, Yaounde, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWomen in sub-Saharan Africa are disproportionately affected by the HIV epidemic. Young women are twice as likely to be living with HIV as men of the same age and account for 64% of new HIV infections among young people. Many studies suggest that financial needs, alongside biological susceptibility, are a leading cause of the gender disparity in HIV acquisition. New robust evidence suggests women adopt risky sexual behaviours to cope with economic shocks, the sudden decreases in household's income or consumption power, enhancing our understanding of the link between poverty and HIV. We investigated if health insurance protects against economic shocks, reducing the need for vulnerable women to engage in risky sexual behaviours and reducing HIV and sexually transmitted infection (STI) incidence. METHOD AND

findingsWe conducted a randomised controlled trial to test the effectiveness of a formal shock coping strategy to prevent HIV among women at high risk of HIV (registration number: ISRCTN 22516548). Between June and August 2021, we recruited 1,508 adolescent girls and women over age 15 years who were involved in transactional sex (n = 753) or commercial sex (n = 755), using snowball sampling. Participants were randomly assigned (1:1) to receive free health insurance for themselves and their economic dependents for 12 months either at the beginning of the study (intervention; n = 579; commercial sex n = 289, transactional sex n = 290) from November 2021 or at the end of the study 12 months later (control; n = 568; commercial sex n = 290, transactional sex n = 278). We collected data on socioeconomic characteristics of participants. Primary outcomes included incidence of HIV and STIs and were measured at baseline, 6 months after randomisation, and 12 months after randomisation. We found that study participants who engaged in transactional sex and were assigned to the intervention group were less likely to become infected with HIV post-intervention (combined result of 6 months post-intervention or 12 months post-intervention, depending on the follow-up data available; odds ratio (OR) = 0.109 (95% confidence interval (CI) [0.014, 0.870]); p = 0.036). There was no evidence of a reduction in HIV incidence among women and girls involved in commercial sex. There was also no effect on STI acquisition among both strata of high-risk sexual activity. The main limitations of this study were the challenges of collecting reliable STI incidence data and the low incidence of HIV in women and girls involved in commercial sex, which might have prevented detection of study effects.

conclusionThe study provides to our knowledge the first evidence of the effectiveness of a formal shock coping strategy for HIV prevention among women who engage in transactional sex in Africa, reinforcing the importance of structural interventions to prevent HIV.

trial registrationThe trial was registered with the ISRCTN Registry: ISRCTN 22516548. Registered on 31 July 2021.

Indexed as

HIV InfectionsAdolescentAdultCameroonFemaleHumansIncidenceInsurance, HealthMalePovertySexual BehaviorSex WorkSex WorkersYoung Adult

Identifiers

PMID39446721
PMCPMC11500901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.